Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells

International Immunology

Volumn 23, Issue 3, 2011, Pages 185-193

  Suzuki, Kaori ^a   Murakami, Taisuke ^a   Kuwahara Arai, Kyoko ^a   Tamura, Hiroshi ^b   Hiramatsu, Keiichi ^a   Nagaoka, Isao ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seikagaku Biobusiness Corporation   (Japan)

Author keywords

CAP18; Endotoxin shock; LPS neutralization; Organ dysfunction; Sepsis

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD14 ANTIGEN; GALACTOSAMINE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIVER CELL; LUNG ALVEOLUS CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

EID: 79952583993     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq471     Document Type: Article

References (44)

1. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420:885.
2. Van Amersfoort, E. S., Van Berkel, T. J. and Kuiper, J. 2003. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin. Microbiol. Rev. 16:379.
3. Pinsky, M. R. 2004. Dysregulation of the immune response in severe sepsis. Am. J. Med. Sci. 328:220.
4. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135.
5. Aird, W. C. 2003. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101:3765.
6. Vallet, B. 2003. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit. Care. 7:130.
7. Matsuda, N. and Hattori, Y. 2007. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J. Smooth Muscle Res. 43:117.
8. Lush, C. W., Cepinskas, G. and Kvietys, P. R. 2000. LPS tolerance in human endothelial cells: reduced PMN adhesion, E-selectin expression, and NF-kappaB mobilization. Am. J. Physiol. Heart Circ. Physiol. 278:H853.
9. Moore, K. L., Andreoli, S. P., Esmon, N. L. et al. 1987. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest. 79:124.
10. Pawlinski, R. and Mackman, N. 2004. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit. Care Med. 32:S293.
11. Bannerman, D. D. and Goldblum, S. E. 2003. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L899.
12. Harlan, J. M., Harker, L. A., Reidy, M. A. et al. 1983. Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab. Invest. 48:269.
13. Wang, H. L., Akinci, I. O., Baker, C. M. et al. 2007. The intrinsic apoptotic pathway is required for lipopolysaccharide-induced lung endothelial cell death. J. Immunol. 179:1834.
14. Hull, C., McLean, G., Wong, F. et al. 2002. Lipopolysaccharide signals an endothelial apoptosis pathway through TNF receptorassociated factor 6-mediated activation of c-Jun NH2-terminal kinase. J. Immunol. 169:2611.
15. Dauphinee, S. M. and Karsan, A. 2006. Lipopolysaccharide signaling in endothelial cells. Lab. Invest. 86:9.
16. Fujita, M., Kuwano, K., Kunitake, R. et al. 1998. Endothelial cell apoptosis in lipopolysaccharide-induced lung injury in mice. Int. Arch. Allergy Immunol. 117:202.
17. Haimovitz-Friedman, A., Cordon-Cardo, C., Bayoumy, S. et al. 1997. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186:1831.
18. Namisaki, T., Yoshiji, H., Kojima, H. et al. 2006. Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats. J. Hepatol. 44:568.
19. Kawasaki, M., Kuwano, K., Hagimoto, N. et al. 2000. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am. J. Pathol. 157:597.
20. Van Oosten, M., Rensen, P. C., Van Amersfoort, E. S. et al. 2001. Apolipoprotein E protects against bacterial lipopolysaccharideinduced lethality. A new therapeutic approach to treat gramnegative sepsis. J. Biol. Chem. 276:8820.
21. Pajkrt, D., Doran, J. E., Koster, F. et al. 1996. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J. Exp. Med. 184:1601.
22. Zanetti, M., Gennaro, R. and Romeo, D. 1995. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374:1.
23. Hirata, M., Shimomura, Y., Yoshida, M. et al. 1994. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect. Immun. 62:1421.
24. Nagaoka, I., Hirota, S., Niyonsaba, F. et al. 2001. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J. Immunol. 167:3329.
25. Rosenfeld, Y., Papo, N. and Shai, Y. 2006. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem. 281:1636.
26. Lloyd, K. L. and Kubes, P. 2006. GPI-linked endothelial CD14 contributes to the detection of LPS. Am. J. Physiol. Heart Circ. Physiol. 291:H473.
27. Lloyd-Jones, K. L., Kelly, M. M. and Kubes, P. 2008. Varying importance of soluble and membrane CD14 in endothelial detection of lipopolysaccharide. J. Immunol. 181:1446.
28. McCord, A. M., Burgess, A. W., Whaley, M. J. et al. 2005. Interaction of Bartonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration. Infect. Immun. 73:5735.
29. Shioiri, T., Muroi, M., Hatao, F. et al. 2009. Caspase-3 is activated and rapidly released from human umbilical vein endothelial cells in response to lipopolysaccharide. Biochim. Biophys. Acta. 1792:1011.
30. Triantafilou, K., Triantafilou, M. and Fernandez, N. 2000. Lipopolysaccharide (LPS) labeled with Alexa 488 hydrazide as a novel probe for LPS binding studies. Cytometry 41:316.
31. Jersmann, H. P., Hii, C. S., Hodge, G. L. et al. 2001. Synthesis and surface expression of CD14 by human endothelial cells. Infect. Immun. 69:479.
32. Karahashi, H., Michelsen, K. S. and Arditi, M. 2009. Lipopolysaccharide-induced apoptosis in transformed bovine brain endothelial cells and human dermal microvessel endothelial cells: the role of JNK. J. Immunol. 182:7280.
33. Nagaoka, I., Niyonsaba, F., Tsutsumi-Ishii, Y. et al. 2008. Evaluation of the effect of human beta-defensins on neutrohil apoptosis. Int. Immunol. 20:543.
34. Galanos, C., Freudenberg,M. A. and Reutter,W. 1979. Galactosamineinduced sensitization to the lethal effects of endotoxin. Proc. Natl Acad. Sci. USA. 76:5939.
35. Murakami, T., Obata, T., Kuwahara-Arai, K. et al. 2009. Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice. Int. Immunol. 21:905.
36. Johansson, J., Gudmundsson, G. H., Rottenberg, M. E. et al. 1998. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273:3718.
37. Koczulla, R., von Degenfeld, G., Kupatt, C. et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111:1665.
38. Leist, M., Gantner, F., Bohlinger, I. et al. 1995. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146:1220.
39. Jaeschke, H., Fisher, M. A., Lawson, J. A. et al. 1998. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alphainduced hepatic parenchymal cell apoptosis and neutrophilmediated necrosis in a murine endotoxin shock model. J. Immunol. 160:3480.
40. Frey, E. A., Miller, D. S., Jahr, T. G. et al. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665.
41. Bazil, V. and Strominger, J. L. 1991. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 147:1567.
42. Guha, M. and Mackman, N. 2001. LPS induction of gene expression in human monocytes. Cell. Signal. 13:85.
43. Cohen, J. 2000. The detection and interpretation of endotoxaemia. Intensive Care Med. 26 (Suppl. 1):S51.
44. Suzuki, K., Tanaka, M., Watanabe, N. et al. 2008. p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver. Gastroenterology 135:270.